Meal Timing on Glucose and Hyperandrogenism in PCOS Women (MealTimePCOS)
|ClinicalTrials.gov Identifier: NCT01711476|
Recruitment Status : Unknown
Verified January 2013 by Daniela Jakubowicz, MD, Hospital de Clinicas Caracas.
Recruitment status was: Recruiting
First Posted : October 22, 2012
Last Update Posted : January 23, 2013
The objective of this study is to investigate the effects of two isocaloric maintenance diets with different meal timing distribution on insulin resistance hyperandrogenism and cytochrome P450c17 alpha activity in lean PCOS women.
The investigators hypothesis is that in lean PCOS women a Breakfast Diet (BD) which consist in high calorie breakfast and reduced dinner, vs Dinner Diet (DD) which consist in high calorie dinner with reduced breakfast; the BD will improve glucose and insulin response to OGTT and would decrease the hyperandrogenism and cytochrome P450c17 alpha activity.
|Condition or disease||Intervention/treatment||Phase|
|Polycystic Ovary Syndrome (PCOS) Women||Behavioral: Placebo Comparator: Lifestyle counseling Dinner Diet ARM 2 Other: Active Comparator: Lifestyle counseling ARM 1||Not Applicable|
Hyperinsulinemia plays a central role in the pathogenesis in obese as well as in lean PCOS women. These women are insulin resistant and have compensatory hyperinsulinemia that stimulates ovarian cytochrome P450c17 alpha activity that in turn stimulates ovarian androgen concentrations.
In obese PCOS women, weight loss improves insulin resistance and hyperandrogenism, resulting in improvement of clinical symptoms.
Since lean PCOS women do not have the option of weight loss, it is important to know if composition and meal timing distribution may influence glucose metabolism and hyperandrogenism and cytochrome P450c17 alpha activity. We hypothesized that a timing pattern of increased nutrient intake of protein and carbohydrates in the morning, with decreased caloric intake at night would improve insulin sensitivity and hyperandrogenism in lean women with PCOS
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Influence of Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||January 2013|
|Estimated Study Completion Date :||January 2013|
Active Comparator: Lifestyle counseling ARM 1
Arm 1 Breakfast Diet The arm 1 will be assigned to eat High calorie breakfast (800kcal) and reduced dinner (200 kcal) During 90 days from baseline to the end of the trial (day 90)
Other: Active Comparator: Lifestyle counseling ARM 1
In the Arm 1 we will measure androgen levels and insulin and glucose response to OGTT at baseline DAY 0 and after 90 days on the dinner diet (Day 90) for comparison Also we will evaluate by weekly progesterone the ovulatory events
Other Name: Lean PCOS women in ARM 1 will be assigned to Breakfast diet from Day 0 to day 90 of the study
Placebo Comparator: Lifestyle counseling ARM 2
Lean PCOS women in the Arm 2 will be assigned to do a dinner diet from day 0 to day 90 of the trial
Behavioral: Placebo Comparator: Lifestyle counseling Dinner Diet ARM 2
In this Arm 2 group the PCOS will be assigned to dinner diet and we will compare the androgen levels Day 0 to androgen after DAY 90 of this diet also we will compare Glucose and Insulin response to OGTT Day 0 and Day 90, and ovulatory frequency along alll the 90 days of the Dinner diet
Other Name: The lean PCOS patients assigned to dinner diet
- Changes in Androgens and 17 alpha hydroxyprogesterone serum levels [ Time Frame: 90 days ]The androgens (testosterone, free testosterone, DHEA-S, androstenedione)and 17 alpha hydroxyprogesterone will be measured at baseline and again will be measured at the end of the trial by day 90. In both groups or Arms one on breakfast diet and the other on dinner diet.
- Glucose and Insulin Response to OGTT [ Time Frame: 90 ]Glucose and Insulin Response to OGTT will be measured at baseline and again will be repeated after 90 days of the trial for comparison One group will be assigned to breakfast diet and the other group to dinner diet
- Ovulatory frequency [ Time Frame: 90 days ]From baseline (day O) to the end of the study (day 90) progesterone will be quantified weekly to assess the ovulation in both of the group (The ovulation in the breakfast diet group will be compared to that of the dinner diet group)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01711476
|Contact: Daniela Jakubowicz, MDfirstname.lastname@example.org|
|Caracas, San Bernardino, Venezuela, 410|
|Principal Investigator: Daniela Jakubowicz, MD|
|Principal Investigator:||Daniela Jakubowicz, MD||Hospital de Clinicas Caracas|